These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23225895)

  • 1. Plasmodium falciparum drug resistance phenotype as assessed by patient antimalarial drug levels and its association with pfmdr1 polymorphisms.
    Malmberg M; Ferreira PE; Tarning J; Ursing J; Ngasala B; Björkman A; Mårtensson A; Gil JP
    J Infect Dis; 2013 Mar; 207(5):842-7. PubMed ID: 23225895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda.
    Baraka V; Mavoko HM; Nabasumba C; Francis F; Lutumba P; Alifrangis M; Van Geertruyden JP
    PLoS One; 2018; 13(2):e0191922. PubMed ID: 29390014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.
    Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S
    Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania.
    Malmberg M; Ngasala B; Ferreira PE; Larsson E; Jovel I; Hjalmarsson A; Petzold M; Premji Z; Gil JP; Björkman A; Mårtensson A
    Malar J; 2013 Mar; 12():103. PubMed ID: 23506218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin.
    Wurtz N; Fall B; Pascual A; Fall M; Baret E; Camara C; Nakoulima A; Diatta B; Fall KB; Mbaye PS; Diémé Y; Bercion R; Wade B; Pradines B
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7032-40. PubMed ID: 25199781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmodium falciparum Polymorphisms associated with ex vivo drug susceptibility and clinical effectiveness of artemisinin-based combination therapies in Benin.
    Dahlström S; Aubouy A; Maïga-Ascofaré O; Faucher JF; Wakpo A; Ezinmègnon S; Massougbodji A; Houzé P; Kendjo E; Deloron P; Le Bras J; Houzé S
    Antimicrob Agents Chemother; 2014; 58(1):1-10. PubMed ID: 24100489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of antimalarial treatment and chemoprevention on the drug sensitivity of malaria parasites isolated from ugandan children.
    Tumwebaze P; Conrad MD; Walakira A; LeClair N; Byaruhanga O; Nakazibwe C; Kozak B; Bloome J; Okiring J; Kakuru A; Bigira V; Kapisi J; Legac J; Gut J; Cooper RA; Kamya MR; Havlir DV; Dorsey G; Greenhouse B; Nsobya SL; Rosenthal PJ
    Antimicrob Agents Chemother; 2015; 59(6):3018-30. PubMed ID: 25753626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia.
    Lim P; Alker AP; Khim N; Shah NK; Incardona S; Doung S; Yi P; Bouth DM; Bouchier C; Puijalon OM; Meshnick SR; Wongsrichanalai C; Fandeur T; Le Bras J; Ringwald P; Ariey F
    Malar J; 2009 Jan; 8():11. PubMed ID: 19138391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.
    Kavishe RA; Paulo P; Kaaya RD; Kalinga A; van Zwetselaar M; Chilongola J; Roper C; Alifrangis M
    Malar J; 2014 Jul; 13():264. PubMed ID: 25007802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the pfmdr1 gene and in vitro artemether and lumefantrine sensitivity in Thai isolates of Plasmodium falciparum.
    Mungthin M; Khositnithikul R; Sitthichot N; Suwandittakul N; Wattanaveeradej V; Ward SA; Na-Bangchang K
    Am J Trop Med Hyg; 2010 Nov; 83(5):1005-9. PubMed ID: 21036827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in northern KwaZulu-Natal: an observational cohort study.
    Vaughan-Williams CH; Raman J; Raswiswi E; Immelman E; Reichel H; Gate K; Knight S
    Malar J; 2012 Dec; 11():434. PubMed ID: 23272998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of N86F184D1246 haplotype of Pfmrd1 gene by artemether-lumefantrine drug pressure on Plasmodium falciparum populations in Senegal.
    Mbaye A; Dieye B; Ndiaye YD; Bei AK; Muna A; Deme AB; Yade MS; Diongue K; Gaye A; Ndiaye IM; Ndiaye T; Sy M; Diallo MA; Badiane AS; Ndiaye M; Seck MC; Sy N; Koita O; Krogstad DJ; Nwakanma D; Ndiaye D
    Malar J; 2016 Aug; 15(1):433. PubMed ID: 27562216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Balanced impacts of fitness and drug pressure on the evolution of PfMDR1 polymorphisms in Plasmodium falciparum.
    Duvalsaint M; Conrad MD; Tukwasibwe S; Tumwebaze PK; Legac J; Cooper RA; Rosenthal PJ
    Malar J; 2021 Jun; 20(1):292. PubMed ID: 34193148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of pfmdr1 alleles associated with artemether-lumefantrine tolerance/resistance in Maputo before and after the implementation of artemisinin-based combination therapy.
    Lobo E; de Sousa B; Rosa S; Figueiredo P; Lobo L; Pateira S; Fernandes N; Nogueira F
    Malar J; 2014 Aug; 13():300. PubMed ID: 25098280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
    Lekana-Douki JB; Dinzouna Boutamba SD; Zatra R; Zang Edou SE; Ekomy H; Bisvigou U; Toure-Ndouo FS
    Infect Genet Evol; 2011 Mar; 11(2):512-7. PubMed ID: 21251998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged selection of pfmdr1 polymorphisms after treatment of falciparum malaria with artemether-lumefantrine in Uganda.
    Baliraine FN; Rosenthal PJ
    J Infect Dis; 2011 Oct; 204(7):1120-4. PubMed ID: 21881128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of parasites with diminished drug susceptibility by amodiaquine-containing antimalarial regimens in Uganda.
    Nawaz F; Nsobya SL; Kiggundu M; Joloba M; Rosenthal PJ
    J Infect Dis; 2009 Dec; 200(11):1650-7. PubMed ID: 19905933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid selection of Plasmodium falciparum chloroquine resistance transporter gene and multidrug resistance gene-1 haplotypes associated with past chloroquine and present artemether-lumefantrine use in Inhambane District, southern Mozambique.
    Thomsen TT; Madsen LB; Hansson HH; Tomás EV; Charlwood D; Bygbjerg IC; Alifrangis M
    Am J Trop Med Hyg; 2013 Mar; 88(3):536-41. PubMed ID: 23382159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatio-temporal distribution of PfMDR1 polymorphism among uncomplicated Plasmodium falciparum malaria cases along international border of north east India.
    Goomber S; Mishra N; Anvikar A; Yadav CP; Valecha N
    Infect Genet Evol; 2018 Sep; 63():285-290. PubMed ID: 29842979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel polymorphisms in Plasmodium falciparum ABC transporter genes are associated with major ACT antimalarial drug resistance.
    Veiga MI; Ferreira PE; Jörnhagen L; Malmberg M; Kone A; Schmidt BA; Petzold M; Björkman A; Nosten F; Gil JP
    PLoS One; 2011; 6(5):e20212. PubMed ID: 21633513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.